Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation

Transplantation

Volumn 62, Issue 5, 1996, Pages 681-688

  Tanaka, Mitsuko ^a   Murase, Noriko ^a   Ye, Qing ^a   Miyazaki, Wasei ^b   Nomoto, Minoru ^a   Miyazawa, Hideaki ^a   Manez, Rafael ^a   Toyama, Yoichi ^a   Demetris, Anthony J ^a   Todo, Satoru ^a   Starzl, Thomas E ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT INHIBITOR; CYCLOPHOSPHAMIDE; K 76; TACROLIMUS; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG HALF LIFE; DRUG MECHANISM; DRUG MIXTURE; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIG; HAMSTER; HEART TRANSPLANTATION; INTRAGASTRIC DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; XENOTRANSPLANTATION;

EID: 9544227469     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609150-00025     Document Type: Article

References (34)

1. Miyazaki W, Tamaoka H, Shinohara M, et al. A complement inhibitor produced by Stachybotrys complement nov. sp. K76, a new species of fungi imperfecti. Microbiol Immunol 1980; 24: 1091.
2. Hong K, Kinoshita T, Miyazaki W, Izawa T, Inoue K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J Immunol 1979; 122: 2418.
3. Miyazaki W, Izawa T, Nakano Y, et al. Effects of K-76 monocarboxylic acid, an anticomplementary agent, on various in vivo immunological reactions and on experimental glomerulonephritis. Complement 1984; 1: 134.
4. Iida H, Izumino K, Asaka M, Takata M, Mizumura Y, Sasayama S. Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats. Clin Exp Immunol 1987; 67: 130.
5. Kitano A, Matsumoto T, Nakamura S, et al. Multifunctional effects of anticomplementary agent K-76 on carrageenan-induced colitis in the rabbit. Clin Exp Immunol 1993; 94: 348.
6. Kitano A, Matsumoto T, Nakamura S, et al. New treatment of ulcerative colitis by K-76. Dis Colon Rectum 1992; 35: 560.
7. Miyagawa S, Shirakura R, Matsumiya G, et al. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175. Transplantation 1993; 55: 709.
8. Starzl TE, Tzakis A, Fung JJ, et al. Prospects of clinical xenotransplantation. Transplant Proc 1994; 26: 1082.
9. Tanaka M, Murase N, Miyazawa H, et al. The effect of anticomplement agent, K-76 COOH in hamster-to-rat and guinea pig-to-rat heart transplantation. Transplant Proc 1995; 27: 275.
10. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
11. Yamamoto I, Muto N, Murakami K, Suga S. An enzyme immunoassay for K-76 monocarboxylic acid, a novel anticomplementary compound. J Immunoassay 1989; 10: 153.
12. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM, eds. Experimental immunochemistry, 2nd ed. Springfield, IL: Charles C Thomas, 1961; 133.
13. Murase N, Starzl TE, Demetris AJ, et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55: 701.
14. Valdivia LA, Demetris AJ, Fung JJ, Celli S, Murase N, Starzl TE: Successful hamster to rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation 1993; 55: 659.
15. Starzl TE. Patters of permissible donor-recipient tissue transfer in relation to ABO blood groups. In: Starzl TE, ed. Experience in renal transplantation. Philadelphia: Saunders, 1964: 37.
16. Terasaki PI, Marchioro TL, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. In: Histocompatibility testing. Washington, DC: National Academy of Sciences, National Research Council, 1965: 83.
17. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with preexisting humoral antibodies against donor cells. Lancet 1966; 2: 622.
18. Perper RJ, Najarian JS. Experimental renal heterotransplantation. I. In widely divergent species. Transplantation 1966; 4: 377.
19. Gewurz H, Clark DS, Cooper ND, Varco RL, Good RA. Effect of cobra venom-induced inhibition of complement activity on allograft and xeno graft rejection reactions. Transplantation 1967; 5: 1296.
20. Starzl TE, Lerner RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI. Shwarzman reaction after human renal transplantation. N Engl J Med 1968; 278: 642.
21. Starzl TE, Boehmig HJ, Amemiya H, et al. Clotting changes, including disseminated intravascular coagulation, during rapid renal homograft rejection. N Engl J Med 1970; 283: 383.
22. Starzl TE, Valdivia LA, Murase N, et al. The biologic basis of and strategies for clinical xenotransplantation. Immunol Rev 1994; 141: 213.
23. Nelson RA. A new concept of immunosuppression in the hypersensitivity reactions and in transplantation immunity. Surv Opthalmol 1966; 11: 498.
24. Cochrane CG, Muller-Eberhard HJ, Aikin BS. Depletion of complement in vivo by a protein of cobra venom: its effect in various immunologic reactions. J Immunol 1970; 105: 55.
25. Pruitt SK, Baldwin WM, Marsh HC, Lin SS, Yeh CG, Bollinger RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991; 52: 868.
26. Xia W, Fearon DT, Kirkman RL. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplant Proc 1993; 25: 410.
27. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection of porcine xenografts. Transplantation 1994; 57: 363.
28. Miyazawa H, Murase N, Demetris AJ, et al. Hamster to rat kidney xenotransplantation. Transplantation 1995; 59: 1183.
29. Miyagawa S, Hirose H, Shirakura R, et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
30. Soares M, Lu X, Havaux X, et al. In vivo IgM depletion by anti-μ monoclonal antibody therapy: the role of IgM in hyperacute vascular rejection of discordant xenografts. Transplantation 1994; 57: 1003.
31. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
32. Adachi H, Rosengard Br, Hutchins GM, et al. Effects of cyclosporine, aspirin, and cobra venom factor on discordant cardiac xenograft survival in rats. Transplant Proc 1987; 19: 1145.
33. Van den Bogaerde JB, Aspinall R, Wang MW, et al. Induction of long-term survival of hamster heart xenografts in rats. Transplantation 1991; 52: 15.
34. Hasan R, Van Den Bogaerde JB, Wallwork J, White DJG. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992; 54: 408.